Search results
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 1 hour agoThe company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around $0.3bn in net sales for the first half of the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 13 hours agoThose products could range from RSV vaccines to individualized cancer treatments, which will help...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 24 hours agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 3 hours agoAnd help us understand, as you've communicated with large retail pharmacy, how significant the PFS formulation is to them? A: (Stephane Bancel -
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 23 hours agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 24 hours agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 22 hours agoStrategic Developments and Future Outlook Moderna's CEO, Stephane Bancel, emphasized the company's...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 22 hours agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 23 hours agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
